Profile
VNRX DHR-PB TMO DHR IDXX A
Company Name VolitionRx Limited Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $52.35M $916.76B $159.89B $142.45B $38.24B $30.97B
Employees 0.09K 79.00K 125.00K 61.00K 11.00K 17.90K
CEO Mr. Cameron Reynolds MBA Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
VNRX DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
VNRX DHR-PB TMO DHR IDXX A
Last Close $0.5195 $1261.26 $407.85 $193.09 $486.61 $107.52
High 52 $0.88 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $0.46 $1261.26 $407.02 $174.64 $361.04 $99.29
Price vs. 52 Week High -40.97 % 0 % -34.66 % -31.23 % -11.29 % -30.47 %
Price vs. 52 Week Low 12.93 % 0 % 0.2 % 10.56 % 34.78 % 8.29 %
Total Return
VNRX DHR-PB TMO DHR IDXX A
1 Month Return 12.93 % 0 % -2.8 % 10.56 % 34.78 % 8.29 %
3 Month Return -11.95 % 0 % -28.63 % -6.66 % 5.84 % -25.96 %
6 Month Return -25.11 % 0 % -26.08 % -21.31 % 12.31 % -21.33 %
9 Month Return -8.86 % 0 % -32.03 % -28.12 % 0.56 % -21.38 %
YTD Return -13.42 % 0 % -21.6 % -15.88 % 17.7 % -19.96 %
1 Year Return -29.42 % 0 % -28.9 % -22.62 % -0.09 % -24.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VNRX DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.57 % 0.38 % 0.57 % - 0.89 %
Dividend Paid and Capex Coverage Ration (TTM) -44.71 % 2.93 % 4.05 % 2.93 % 7.41 % 3.01 %
Dividend Per Share (TTM) - 1.13 % 1.6 % 1.13 % - 0.97 %
Payout Ratio (TTM) - 20.85 % 9.16 % 20.85 % - 21.92 %
Growth
VNRX DHR-PB TMO DHR IDXX A
Asset Growth -66.37 % 1.03 % 10.06 %
Gross Profit Growth 59.1 % 8.63 % 2.02 %
Revenue Growth 59.1 % 6.46 % -4.73 %
Revenue 3 Year 733.69 % 25.23 % 8 %
Revenue 5 Year 3166.96 % 69.09 % 36.52 %
Revenue 10 Year 1195.37 % 218.38 % 7.08 %
EBIT Growth 24.08 % 3.47 % 3.77 %
Net Income Growth 23.65 % 5.07 % 3.95 %
Net Income 3 Yeari Growth Per Share 39.15 % 23.15 % 11.67 %
Net Income 5 Yeari Growth Per Share 23.82 % 116.76 % 30.32 %
Net Income 10 Yeari Growth Per Share 49.02 % 492.42 % 197.81 %
Operating Income Growth 24.9 % 2.84 % 10.22 %
Operating Cash Flow Growth (CFG) -43.35 % 2.48 % -1.19 %
Operating 3 Year CFG 24.44 % 27.03 % 23.6 %
Operating 5 Year CFG 7.97 % 111.28 % 85.69 %
Operating 10 Year CFG 2.91 % 378.1 % 182 %
EPS Growth 38 % 5.9 % 5.21 %
EPS Diluted Growth 38 % 6.06 % 5.73 %
Book Value Per Share -146.69 % 8.24 % 2.3 %
Share Holder 3 Year Equity Growth Per Share -184.47 % 138.87 % 14.73 %
Share Holder 5 Year Equity Growth Per Share -179.43 % 838.67 % 34.5 %
Share Holder 10 Year Equity Growth Per Share -1150.38 % 1547.69 % 27.76 %
Dividend Per Share Growth - - 4.82 %
Dividend 3 Year Growth Per Share - - 21.71 %
Dividend 5 Year Growth Per Share - - 44.02 %
Dividend 10 Year Growth Per Share - - 78.77 %
Debt Growth -68.12 % -7.53 % 23.95 %
Free Cash Flow Growth -36.69 % 3.26 % -6.85 %
Updated On 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
VNRX DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 21.38 % 59.74 % 41.74 % 59.74 % 61.32 % 53.97 %
Return on Assets TTM -286.91 % 4.76 % 6.58 % 4.76 % 27.85 % 10.57 %
Return on Equity TTM 128.69 % 7.47 % 13.34 % 7.47 % 57.35 % 20.95 %
Return on Capital Employed TTM -1679.85 % 6.66 % 8.53 % 6.66 % 55.24 % 14.73 %
Net Income Per EBT TTM 98.94 % 83.59 % 92.18 % 83.59 % 79.59 % 84.78 %
EBT Per Ebit TTM 100.86 % 93.35 % 96.45 % 93.35 % 97.98 % 100.34 %
EBIT Per Revenue TTM -2190.9 % 20.26 % 17.08 % 20.26 % 29.19 % 22.65 %
Cash Flow To Debt Ratio TTM -440.8 % 37.92 % 23.81 % 37.92 % 91.41 % 50.46 %
Receivables Turnover TTM 11.16 6.79 5.07 6.79 6.51 4.92
Payables Turnover TTM 0.35 5.57 - 5.57 12.66 5.5
Inventory Turnover TTM - 3.79 4.78 3.79 3.84 3.02
Fixed Asset Turnover TTM 24.53 % 466.14 % 459.74 % 466.14 % 471.66 % 359.75 %
Asset Turnover TTM 13.12 % 30.11 % 43.31 % 30.11 % 122.35 % 54.83 %
Operating Cash Flow Per Share TTM -0.27 8.72 21.53 8.72 11.74 5.95
Free Cash Flow Per Share TTM -0.27 6.84 17.79 6.84 10.16 4.6
Cash Per Share TTM 3.4 % 278.24 % 1573.28 % 278.24 % 198.83 % 514.74 %
Operating Cash Flow Sales Ratio TTM -2080.02 % 26.23 % 18.97 % 26.23 % 24.63 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.22 % 78.46 % 82.61 % 78.46 % 86.51 % 77.31 %
Cash Flow Coverage Ratios TTM -440.8 % 37.92 % 23.81 % 37.92 % 91.41 % 50.46 %
Price To Free Cash Flows Ratio TTM -2 29.06 23.78 29.06 45.65 23.61
Price To Operating Cash Flows Ratio TTM -1.95 22.82 19.67 22.82 40.19 18.24
Price Cash Flow Ratio TTM -1.95 22.82 19.67 22.82 40.19 18.24
Income Statement (TTM)
VNRX DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $-0B $14.21B $17.7B $14.21B $2.38B $3.54B
Gross Profit Ratio -5.57% 59.5% 41.28% 59.5% 61.04% 54.3%
EBITDA $-0.03B $7.28B $11.8B $7.28B $1.28B $1.87B
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -0.31 5.29 16.53 5.29 10.67 4.43
Balance Sheet (MRQ)
VNRX DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.55B $3.35B
Total Liabilities $0.04B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $-0.03B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0.01B $16.01B $31.28B $16.01B $0.99B $3.39B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
VNRX DHR-PB TMO DHR IDXX A
Net Income $-0.03B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.03B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 108.67
ACRS Aclaris Therapeutics, Inc. 1.315
ADVB Advanced Biomed Inc. Common Stock 1.06
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.8457
AWH Aspira Women's Health Inc. 0.082
BDSX Biodesix, Inc. 0.3452
BIAF bioAffinity Technologies, Inc. 0.2015
BIAFW bioAffinity Technologies, Inc. 0.1711
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.86
BNR Burning Rock Biotech Limited 2.395
CDNA CareDx, Inc 15.405
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.87
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 141.77
CSTL Castle Biosciences, Inc. 17.19
DGX Quest Diagnostics Incorporated 175.92
ETFs With Exposure to VNRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00003 123.45
VXF Vanguard Extended Market Index Fund 0 177.365
IWC iShares Micro-Cap ETF 0.00282 114.505
STSB iShares Factors US Small Blend Style ETF 0.01 22.13
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.11
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000464909 94.75
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 132.12
VEMPX Vanguard Extended Market Index InstlPlus 0 326.02
Unlock